[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:primary-mediastinal-large-b-cell-lymphoma:bcl6-gene":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Primary Mediastinal Large B-Cell Lymphoma","BCL6 Gene",3,[8,16,22],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT04792489","DALY II USA\u002F MB-CART2019.1 for DLBCL",[12],"Phase 2","RECRUITING","2026-08-26T02:16:01.910993Z","2026-07-19T19:36:05.118465Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06788964","Loncastuximab Tesirine and Rituximab as Bridging Therapy Before Standard-of-care CAR-T Therapy in Patients With Large B-cell Lymphoma (CORAL)",[12],"2026-08-26T02:18:45.196599Z","2026-07-05T05:32:16.700465Z",{"nct_id":23,"title":24,"phases":25,"status":26,"updated_at":27,"content_modified":28},"NCT07588698","Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma",[12],"NOT_YET_RECRUITING","2026-08-26T02:16:49.565137Z","2026-05-29T15:36:40.200627Z"]